TY - JOUR AU - Symmons, D. AU - Turner, G. AU - Webb, R. AU - Asten, P. AU - Barrett, E. AU - Lunt, M. PY - 2002 DA - 2002// TI - The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century JO - Rheumatology (Oxford) VL - 41 UR - https://doi.org/10.1093/rheumatology/41.7.793 DO - 10.1093/rheumatology/41.7.793 ID - Symmons2002 ER - TY - JOUR AU - Gelfand, J. M. AU - Gladman, D. D. AU - Mease, P. J. AU - Smith, N. AU - Margolis, D. J. AU - Nijsten, T. PY - 2005 DA - 2005// TI - Epidemiology of psoriatic arthritis in the population of the United States JO - J Am Acad Dermatol VL - 53 UR - https://doi.org/10.1016/j.jaad.2005.03.046 DO - 10.1016/j.jaad.2005.03.046 ID - Gelfand2005 ER - TY - JOUR AU - Wong, K. L. AU - Lee, K. B. L. AU - Tai, B. C. AU - Law, P. PY - 2013 DA - 2013// TI - Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up JO - Arthroscopy VL - 29 UR - https://doi.org/10.1016/j.arthro.2013.09.074 DO - 10.1016/j.arthro.2013.09.074 ID - Wong2013 ER - TY - JOUR AU - Gladman, D. D. AU - Shuckett, R. AU - Russell, M. L. AU - Thorne, J. C. AU - Schachter, R. K. PY - 1987 DA - 1987// TI - Psoriatic arthritis (PSA)--an analysis of 220 patients JO - Q J Med VL - 62 ID - Gladman1987 ER - TY - JOUR AU - Moll, J. M. AU - Wright, V. PY - 1973 DA - 1973// TI - Psoriatic arthritis JO - Semin Arthritis Rheum VL - 3 UR - https://doi.org/10.1016/0049-0172(73)90035-8 DO - 10.1016/0049-0172(73)90035-8 ID - Moll1973 ER - TY - JOUR AU - Veale, D. J. AU - Barnes, L. AU - Rogers, S. AU - FitzGerald, O. PY - 1994 DA - 1994// TI - Immunohistochemical markers for arthritis in psoriasis JO - Ann Rheum Dis VL - 53 UR - https://doi.org/10.1136/ard.53.7.450 DO - 10.1136/ard.53.7.450 ID - Veale1994 ER - TY - JOUR AU - Taylor, P. C. AU - Moore, A. AU - Vasilescu, R. AU - Alvir, J. AU - Tarallo, M. PY - 2016 DA - 2016// TI - A structured literature review of the burden of illness and unmet needs in patients with rheumatoid arthritis: a current perspective JO - Rheumatol Int VL - 36 UR - https://doi.org/10.1007/s00296-015-3415-x DO - 10.1007/s00296-015-3415-x ID - Taylor2016 ER - TY - JOUR AU - Lundkvist, J. AU - Kastäng, F. AU - Kobelt, G. PY - 2008 DA - 2008// TI - The burden of rheumatoid arthritis and access to treatment: health burden and costs JO - Eur J Health Econ VL - 8 UR - https://doi.org/10.1007/s10198-007-0088-8 DO - 10.1007/s10198-007-0088-8 ID - Lundkvist2008 ER - TY - JOUR AU - Burmester, G. R. AU - Pope, J. E. PY - 2017 DA - 2017// TI - Novel treatment strategies in rheumatoid arthritis JO - Lancet. VL - 389 UR - https://doi.org/10.1016/S0140-6736(17)31491-5 DO - 10.1016/S0140-6736(17)31491-5 ID - Burmester2017 ER - TY - JOUR AU - Bathon, J. M. AU - Martin, R. W. AU - Fleischmann, R. M. AU - Tesser, J. R. AU - Schiff, M. H. AU - Keystone, E. C. PY - 2000 DA - 2000// TI - A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis JO - N Engl J Med VL - 343 UR - https://doi.org/10.1056/NEJM200011303432201 DO - 10.1056/NEJM200011303432201 ID - Bathon2000 ER - TY - JOUR AU - Genovese, M. C. AU - Bathon, J. M. AU - Martin, R. W. AU - Fleischmann, R. M. AU - Tesser, J. R. AU - Schiff, M. H. PY - 2002 DA - 2002// TI - Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes JO - Arthritis Rheumatism VL - 46 UR - https://doi.org/10.1002/art.10308 DO - 10.1002/art.10308 ID - Genovese2002 ER - TY - JOUR AU - Putte, L. B. A. AU - Atkins, C. AU - Malaise, M. AU - Sany, J. AU - Russell, A. S. AU - Riel, P. PY - 2004 DA - 2004// TI - Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed JO - Ann Rheum Dis VL - 63 UR - https://doi.org/10.1136/ard.2003.013052 DO - 10.1136/ard.2003.013052 ID - Putte2004 ER - TY - JOUR AU - Jacobsson, L. T. AU - Turesson, C. AU - Nilsson, J. -. Å. AU - Petersson, I. F. AU - Lindqvist, E. AU - Saxne, T. PY - 2007 DA - 2007// TI - Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.062497 DO - 10.1136/ard.2006.062497 ID - Jacobsson2007 ER - TY - JOUR AU - Jacobsson, L. T. H. AU - Turesson, C. AU - Gülfe, A. AU - Kapetanovic, M. C. AU - Petersson, I. F. AU - Saxne, T. PY - 2005 DA - 2005// TI - Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis JO - J Rheumatol VL - 32 ID - Jacobsson2005 ER - TY - JOUR AU - Spalding, J. R. AU - Hay, J. PY - 2006 DA - 2006// TI - Cost effectiveness of tumour necrosis factor-α inhibitors as first-line agents in rheumatoid arthritis JO - Pharmacoeconomics. VL - 24 UR - https://doi.org/10.2165/00019053-200624120-00006 DO - 10.2165/00019053-200624120-00006 ID - Spalding2006 ER - TY - JOUR AU - Singh, J. A. AU - Guyatt, G. AU - Ogdie, A. AU - Gladman, D. D. AU - Deal, C. AU - Deodhar, A. PY - 2019 DA - 2019// TI - 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis JO - Arthritis Rheumatol VL - 71 UR - https://doi.org/10.1002/art.40726 DO - 10.1002/art.40726 ID - Singh2019 ER - TY - JOUR AU - Moreland, L. W. AU - Schiff, M. H. AU - Baumgartner, S. W. AU - Tindall, E. A. AU - Fleischmann, R. M. AU - Bulpitt, K. J. PY - 1999 DA - 1999// TI - Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial JO - Ann Intern Med VL - 130 UR - https://doi.org/10.7326/0003-4819-130-6-199903160-00004 DO - 10.7326/0003-4819-130-6-199903160-00004 ID - Moreland1999 ER - TY - JOUR AU - Moreland, L. W. AU - O’Dell, J. R. AU - Paulus, H. E. AU - Curtis, J. R. AU - Bathon, J. M. AU - St. Clair, E. W. PY - 2012 DA - 2012// TI - A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial JO - Arthritis Rheumatism. VL - 64 UR - https://doi.org/10.1002/art.34498 DO - 10.1002/art.34498 ID - Moreland2012 ER - TY - JOUR AU - Mease, P. J. AU - Gladman, D. D. AU - Ritchlin, C. T. AU - Ruderman, E. M. AU - Steinfeld, S. D. AU - Choy, E. H. PY - 2005 DA - 2005// TI - Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial JO - Arthritis Rheumatism VL - 52 UR - https://doi.org/10.1002/art.21306 DO - 10.1002/art.21306 ID - Mease2005 ER - TY - JOUR AU - Fleischmann, R. AU - Pangan, A. L. AU - Song, I. -. H. AU - Mysler, E. AU - Bessette, L. AU - Peterfy, C. PY - 2019 DA - 2019// TI - Upadacitinib versus placebo or adalimumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III, double-blind, randomized controlled trial JO - Arthritis Rheumatol VL - 71 UR - https://doi.org/10.1002/art.41032 DO - 10.1002/art.41032 ID - Fleischmann2019 ER - TY - JOUR AU - Nash, P. AU - Mease, P. J. AU - McInnes, I. B. AU - Rahman, P. AU - Ritchlin, C. T. AU - Blanco, R. PY - 2018 DA - 2018// TI - Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3) JO - Arthritis Research Therapy. VL - 20 UR - https://doi.org/10.1186/s13075-018-1551-x DO - 10.1186/s13075-018-1551-x ID - Nash2018 ER - TY - STD TI - Curtis JR, Jain A, Askling J, Bridges Jr SL, Carmona L, Dixon W, Finckh A, Hyrich K, Greenberg JD, Kremer J, Listing J. A comparison of patient characteristics and outcomes in selected European and US rheumatoid arthritis registries. Semin Arthritis Rheum. 2010;40(1):2–14. WB Saunders. ID - ref22 ER - TY - STD TI - Silman A, Symmons D, Scott DGI, Griffiths I. British society for rheumatology biologics register. Annals Rheumatic Dis. 2003;62:ii28–9. ID - ref23 ER - TY - JOUR AU - Zink, A. AU - Listing, J. AU - Kary, S. AU - Ramlau, P. AU - Stoyanova-Scholz, M. AU - Babinsky, K. PY - 2005 DA - 2005// TI - Treatment persistence in patients receiving biological agents or conventional DMARD therapy JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.031476 DO - 10.1136/ard.2004.031476 ID - Zink2005 ER - TY - JOUR AU - Hetland, M. L. PY - 2005 DA - 2005// TI - DANBIO: a nationwide registry of biological therapies in Denmark JO - Clin Exp Rheumatol VL - 23 ID - Hetland2005 ER - TY - JOUR AU - Mariette, X. AU - Gottenberg, J. -. E. AU - Ravaud, P. AU - Combe, B. PY - 2011 DA - 2011// TI - Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries JO - Rheumatology. VL - 50 UR - https://doi.org/10.1093/rheumatology/keq368 DO - 10.1093/rheumatology/keq368 ID - Mariette2011 ER - TY - JOUR AU - Askling, J. AU - Fored, C. M. AU - Geborek, P. AU - Jacobsson, L. T. AU - Vollenhoven, R. AU - Feltelius, N. PY - 2006 DA - 2006// TI - Swedish registers to examine drug safety and clinical issues in RA JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.045872 DO - 10.1136/ard.2005.045872 ID - Askling2006 ER - TY - JOUR AU - Pérez-Sola, M. J. AU - Torre-Cisneros, J. AU - Perez-Zafrilla, B. AU - Carmona, L. AU - Descalzo, M. A. AU - Gómez-Reino, J. J. PY - 2011 DA - 2011// TI - Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry JO - Medicina clinica VL - 137 UR - https://doi.org/10.1016/j.medcli.2010.11.032 DO - 10.1016/j.medcli.2010.11.032 ID - Pérez-Sola2011 ER - TY - JOUR AU - Kremer, J. PY - 2005 DA - 2005// TI - The CORRONA database JO - Annals Rheumatic Dis VL - 64 UR - https://doi.org/10.1136/ard.2005.043497 DO - 10.1136/ard.2005.043497 ID - Kremer2005 ER - TY - JOUR AU - Mikuls, T. R. AU - Kazi, S. AU - Cipher, D. AU - Hooker, R. AU - Kerr, G. S. AU - Richards, J. S. PY - 2007 DA - 2007// TI - The association of race and ethnicity with disease expression in male US veterans with rheumatoid arthritis JO - J Rheumatol VL - 34 ID - Mikuls2007 ER - TY - JOUR AU - Hetland, M. L. AU - Christensen, I. J. AU - Tarp, U. AU - Dreyer, L. AU - Hansen, A. AU - Hansen, I. T. PY - 2010 DA - 2010// TI - Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry JO - Arthritis Rheumatism VL - 62 UR - https://doi.org/10.1002/art.27227 DO - 10.1002/art.27227 ID - Hetland2010 ER - TY - BOOK AU - Kirby, C. PY - 2019 DA - 2019// TI - Initial analysis of prescribing trends on primary care reimbursement services hub ID - Kirby2019 ER - TY - JOUR AU - Blum, M. A. AU - Koo, D. AU - Doshi, J. A. PY - 2011 DA - 2011// TI - Measurement and rates of persistence with and adherence to biologics for rheumatoid arthritis: a systematic review JO - Clin Ther VL - 33 UR - https://doi.org/10.1016/j.clinthera.2011.06.001 DO - 10.1016/j.clinthera.2011.06.001 ID - Blum2011 ER - TY - JOUR AU - Harrold, L. R. AU - Stolshek, B. S. AU - Rebello, S. AU - Collier, D. H. AU - Mutebi, A. AU - Wade, S. W. PY - 2017 DA - 2017// TI - Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry JO - Clin Rheumatol VL - 36 UR - https://doi.org/10.1007/s10067-017-3593-x DO - 10.1007/s10067-017-3593-x ID - Harrold2017 ER - TY - JOUR AU - Lyu, R. AU - Govoni, M. AU - Ding, Q. AU - Black, C. M. AU - Kachroo, S. AU - Fan, T. PY - 2016 DA - 2016// TI - Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany JO - Rheumatol Int VL - 36 UR - https://doi.org/10.1007/s00296-015-3348-4 DO - 10.1007/s00296-015-3348-4 ID - Lyu2016 ER - TY - JOUR AU - Mahlich, J. AU - Sruamsiri, R. PY - 2016 DA - 2016// TI - Persistence with biologic agents for the treatment of rheumatoid arthritis in Japan JO - Patient Preference Adherence VL - 10 UR - https://doi.org/10.2147/PPA.S110147 DO - 10.2147/PPA.S110147 ID - Mahlich2016 ER - TY - JOUR AU - Saber, T. P. AU - Ng, C. T. AU - Renard, G. AU - Lynch, B. M. AU - Pontifex, E. AU - Walsh, C. A. PY - 2010 DA - 2010// TI - Remission in psoriatic arthritis: is it possible and how can it be predicted? JO - Arthritis Research Therapy. VL - 12 UR - https://doi.org/10.1186/ar3021 DO - 10.1186/ar3021 ID - Saber2010 ER - TY - JOUR AU - Vander Cruyssen, B. AU - Keyser, F. AU - Kruithof, E. AU - Mielants, H. AU - Bosch, F. PY - 2007 DA - 2007// TI - Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.055541 DO - 10.1136/ard.2006.055541 ID - Vander Cruyssen2007 ER - TY - JOUR AU - Wells, G. AU - Becker, J. -. C. AU - Teng, J. AU - Dougados, M. AU - Schiff, M. AU - Smolen, J. PY - 2009 DA - 2009// TI - Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2007.084459 DO - 10.1136/ard.2007.084459 ID - Wells2009 ER - TY - JOUR AU - Gestel, A. M. AU - Prevoo, M. L. L. AU - Hof, M. A. AU - Rijswijk, M. H. AU - Putte, L. B. A. AU - Riel, P. PY - 1996 DA - 1996// TI - Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis: comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism criteria JO - Arthritis Rheumatism VL - 39 UR - https://doi.org/10.1002/art.1780390105 DO - 10.1002/art.1780390105 ID - Gestel1996 ER - TY - JOUR AU - Gestel, A. M. AU - Haagsma, C. J. AU - Riel, P. L. PY - 1998 DA - 1998// TI - Validation of rheumatoid arthritis improvement criteria that include simplified joint counts JO - Arthritis Rheumatism VL - 41 UR - https://doi.org/3.0.CO;2-K DO - 3.0.CO;2-K ID - Gestel1998 ER - TY - STD TI - Flouri I, Markatseli TE, Voulgari PV, Boki KA, Papadopoulos I, Settas L, et al. Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival. Semin Arthritis Rheumatism. 2014;43(4):447–57. WB Saunders. ID - ref42 ER - TY - JOUR AU - Simard, J. F. AU - Arkema, E. V. AU - Sundstrom, A. AU - Geborek, P. AU - Saxne, T. AU - Baecklund, E. PY - 2011 DA - 2011// TI - Ten years with biologics: to whom do data on effectiveness and safety apply? JO - Rheumatology. VL - 50 UR - https://doi.org/10.1093/rheumatology/keq326 DO - 10.1093/rheumatology/keq326 ID - Simard2011 ER - TY - JOUR AU - Shadick, N. A. AU - Gerlanc, N. M. AU - Frits, M. L. AU - Stolshek, B. S. AU - Brady, B. L. AU - Iannaccone, C. PY - 2019 DA - 2019// TI - The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry JO - Clin Rheumatol VL - 38 UR - https://doi.org/10.1007/s10067-019-04649-4 DO - 10.1007/s10067-019-04649-4 ID - Shadick2019 ER - TY - JOUR AU - Machold, K. P. AU - Stamm, T. A. AU - Nell, V. P. K. AU - Pflugbeil, S. AU - Aletaha, D. AU - Steiner, G. PY - 2007 DA - 2007// TI - Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease JO - Rheumatology. VL - 46 UR - https://doi.org/10.1093/rheumatology/kel237 DO - 10.1093/rheumatology/kel237 ID - Machold2007 ER - TY - JOUR AU - Ujfalussy, I. AU - Koo, E. PY - 2003 DA - 2003// TI - Measurement of disease activity in psoriatic arthritis - extended report JO - Zeitschrift Fur Rheumatologie VL - 62 UR - https://doi.org/10.1007/s00393-003-0455-5 DO - 10.1007/s00393-003-0455-5 ID - Ujfalussy2003 ER - TY - JOUR AU - Balogh, E. AU - Dias, J. M. AU - Orr, C. AU - Mullan, R. AU - Harty, L. AU - FitzGerald, O. PY - 2013 DA - 2013// TI - Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder JO - Arthritis Research Therapy VL - 15 UR - https://doi.org/10.1186/ar4421 DO - 10.1186/ar4421 ID - Balogh2013 ER - TY - STD TI - Madsen OR. AB0941 Patient and physician global assessments reflect strongly diverging attitudes between patients with psoriatic arthritis and their rheumatologists to severity of disease and to the relative importance of different outcome measures. Ann Rheum Dis. 2018;77:1595. https://ard.bmj.com/content/77/Suppl_2/1595.1.info. UR - https://ard.bmj.com/content/77/Suppl_2/1595.1.info ID - ref48 ER - TY - JOUR AU - Eder, L. AU - Haddad, A. AU - Rosen, C. F. AU - Lee, K. -. A. AU - Chandran, V. AU - Cook, R. PY - 2016 DA - 2016// TI - The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study JO - Arthritis Rheumatology. VL - 68 UR - https://doi.org/10.1002/art.39494 DO - 10.1002/art.39494 ID - Eder2016 ER - TY - JOUR AU - Haroon, M. AU - Gallagher, P. AU - FitzGerald, O. PY - 2015 DA - 2015// TI - Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis JO - Ann Rheum Dis VL - 74 UR - https://doi.org/10.1136/annrheumdis-2013-204858 DO - 10.1136/annrheumdis-2013-204858 ID - Haroon2015 ER - TY - JOUR AU - Scott, D. L. AU - Coulton, B. L. AU - Symmons, D. P. M. AU - Popert, A. J. PY - 1987 DA - 1987// TI - Long-term outcome of treating rheumatoid arthritis: results after 20 years JO - Lancet VL - 329 UR - https://doi.org/10.1016/S0140-6736(87)91672-2 DO - 10.1016/S0140-6736(87)91672-2 ID - Scott1987 ER - TY - JOUR AU - Symmons, D. P. AU - Jones, M. A. AU - Scott, D. L. AU - Prior, P. PY - 1998 DA - 1998// TI - Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well JO - J Rheumatol VL - 25 ID - Symmons1998 ER - TY - JOUR AU - Forslind, K. AU - Hafström, I. AU - Ahlmen, M. AU - Svensson, B. PY - 2007 DA - 2007// TI - Sex: a major predictor of remission in early rheumatoid arthritis? JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.056937 DO - 10.1136/ard.2006.056937 ID - Forslind2007 ER - TY - JOUR AU - Højgaard, P. AU - Ballegaard, C. AU - Cordtz, R. AU - Zobbe, K. AU - Clausen, M. AU - Glintborg, B. PY - 2018 DA - 2018// TI - Gender differences in biologic treatment outcomes—a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers JO - Rheumatology. VL - 57 UR - https://doi.org/10.1093/rheumatology/key140 DO - 10.1093/rheumatology/key140 ID - Højgaard2018 ER - TY - JOUR AU - Pedersen, M. AU - Jacobsen, S. AU - Klarlund, M. AU - Frisch, M. PY - 2006 DA - 2006// TI - Socioeconomic status and risk of rheumatoid arthritis: a Danish case-control study JO - J Rheumatol VL - 33 ID - Pedersen2006 ER - TY - JOUR AU - Callahan, L. F. AU - Pincus, T. PY - 1988 DA - 1988// TI - Formal education level as a significant marker of clinical status in rheumatoid arthritis JO - Arthritis Rheumatism VL - 31 UR - https://doi.org/10.1002/art.1780311102 DO - 10.1002/art.1780311102 ID - Callahan1988 ER - TY - JOUR AU - Murray, K. E. AU - Murray, T. E. AU - O’Rourke, A. C. AU - Low, C. AU - Veale, D. J. PY - 2019 DA - 2019// TI - Readability and quality of online information on osteoarthritis: an objective analysis with historic comparison JO - Interact J Med Res VL - 8 UR - https://doi.org/10.2196/12855 DO - 10.2196/12855 ID - Murray2019 ER - TY - JOUR AU - Atzeni, F. AU - Antivalle, M. AU - Pallavicini, F. B. AU - Caporali, R. AU - Bazzani, C. AU - Gorla, R. PY - 2009 DA - 2009// TI - Predicting response to anti-TNF treatment in rheumatoid arthritis patients JO - Autoimmun Rev VL - 8 UR - https://doi.org/10.1016/j.autrev.2009.01.005 DO - 10.1016/j.autrev.2009.01.005 ID - Atzeni2009 ER - TY - JOUR AU - Couderc, M. AU - Gottenberg, J. -. E. AU - Mariette, X. AU - Pereira, B. AU - Bardin, T. AU - Cantagrel, A. PY - 2014 DA - 2014// TI - Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the autoimmunity and rituximab registry JO - Rheumatology. VL - 53 UR - https://doi.org/10.1093/rheumatology/keu176 DO - 10.1093/rheumatology/keu176 ID - Couderc2014 ER - TY - JOUR AU - Tengstrand, B. AU - Carlström, K. AU - Felländer-Tsai, L. AU - Hafström, I. PY - 2003 DA - 2003// TI - Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation JO - J Rheumatol VL - 30 ID - Tengstrand2003 ER - TY - JOUR AU - Tengstrand, B. AU - Carlström, K. AU - Hafström, I. PY - 2002 DA - 2002// TI - Bioavailable testosterone in men with rheumatoid arthritis—high frequency of hypogonadism JO - Rheumatology. VL - 41 UR - https://doi.org/10.1093/rheumatology/41.3.285 DO - 10.1093/rheumatology/41.3.285 ID - Tengstrand2002 ER - TY - JOUR AU - Cutolo, M. AU - Sulli, A. AU - Capellino, S. AU - Villaggio, B. AU - Montagna, P. AU - Pizzorni, C. PY - 2006 DA - 2006// TI - Anti-TNF and sex hormones JO - Ann N Y Acad Sci VL - 1069 UR - https://doi.org/10.1196/annals.1351.037 DO - 10.1196/annals.1351.037 ID - Cutolo2006 ER - TY - JOUR AU - Weinblatt, M. E. PY - 2013 DA - 2013// TI - Methotrexate in rheumatoid arthritis: a quarter century of development JO - Trans Am Clin Climatol Assoc VL - 124 ID - Weinblatt2013 ER - TY - JOUR AU - Elmamoun, M. AU - Chandran, V. PY - 2018 DA - 2018// TI - Role of methotrexate in the management of psoriatic arthritis JO - Drugs. VL - 78 UR - https://doi.org/10.1007/s40265-018-0898-2 DO - 10.1007/s40265-018-0898-2 ID - Elmamoun2018 ER - TY - JOUR AU - Strand, V. AU - Cohen, S. AU - Schiff, M. AU - Weaver, A. AU - Fleischmann, R. AU - Cannon, G. PY - 1999 DA - 1999// TI - Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group JO - Arch Intern Med VL - 159 UR - https://doi.org/10.1001/archinte.159.21.2542 DO - 10.1001/archinte.159.21.2542 ID - Strand1999 ER - TY - JOUR AU - Choi, H. K. AU - Hernán, M. A. AU - Seeger, J. D. AU - Robins, J. M. AU - Wolfe, F. PY - 2002 DA - 2002// TI - Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study JO - Lancet VL - 359 UR - https://doi.org/10.1016/S0140-6736(02)08213-2 DO - 10.1016/S0140-6736(02)08213-2 ID - Choi2002 ER - TY - JOUR AU - Heijde, D. AU - Klareskog, L. AU - Rodriguez-Valverde, V. AU - Codreanu, C. AU - Bolosiu, H. AU - Melo-Gomes, J. PY - 2006 DA - 2006// TI - Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial JO - Arthritis Rheumatism VL - 54 UR - https://doi.org/10.1002/art.21655 DO - 10.1002/art.21655 ID - Heijde2006 ER - TY - JOUR AU - Verstappen, S. M. M. AU - Jacobs, J. W. G. AU - Veen, M. J. AU - Heurkens, A. H. M. AU - Schenk, Y. AU - Borg, E. J. PY - 2007 DA - 2007// TI - Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial) JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2007.071092 DO - 10.1136/ard.2007.071092 ID - Verstappen2007 ER - TY - JOUR AU - Vollenhoven, R. F. AU - Ernestam, S. AU - Geborek, P. AU - Petersson, I. F. AU - Cöster, L. AU - Waltbrand, E. PY - 2009 DA - 2009// TI - Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial JO - Lancet VL - 374 UR - https://doi.org/10.1016/S0140-6736(09)60944-2 DO - 10.1016/S0140-6736(09)60944-2 ID - Vollenhoven2009 ER - TY - BOOK AU - Wilsdon, T. D. AU - Whittle, S. L. AU - Thynne, T. R. AU - Mangoni, A. A. PY - 2019 DA - 2019// TI - Methotrexate for psoriatic arthritis. Cochrane Database of Systematic Reviews ID - Wilsdon2019 ER - TY - JOUR AU - Sheane, B. J. AU - Thavaneswaran, A. AU - Gladman, D. D. AU - Chandran, V. PY - 2016 DA - 2016// TI - Attainment of minimal disease activity using methotrexate in psoriatic arthritis JO - J Rheumatol VL - 43 UR - https://doi.org/10.3899/jrheum.160111 DO - 10.3899/jrheum.160111 ID - Sheane2016 ER - TY - JOUR AU - Lateef, O. AU - Shakoor, N. AU - Balk, R. A. PY - 2005 DA - 2005// TI - Methotrexate pulmonary toxicity JO - Expert Opin Drug Saf VL - 4 UR - https://doi.org/10.1517/14740338.4.4.723 DO - 10.1517/14740338.4.4.723 ID - Lateef2005 ER - TY - JOUR AU - Weinblatt, M. E. PY - 1985 DA - 1985// TI - Toxicity of low dose methotrexate in rheumatoid arthritis JO - J Rheumatol Supplement VL - 12 ID - Weinblatt1985 ER - TY - JOUR AU - Madhok, R. AU - Capell, H. A. PY - 1999 DA - 1999// TI - Outstanding issues in use of disease-modifying agents in rheumatoid arthritis JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(05)74938-2 DO - 10.1016/S0140-6736(05)74938-2 ID - Madhok1999 ER - TY - JOUR AU - Murray, K. E. AU - Moore, L. AU - O’Brien, C. AU - Clohessy, A. AU - Brophy, C. AU - Minnock, P. PY - 2019 DA - 2019// TI - Updated pharmacological management of rheumatoid arthritis for women before, during, and after pregnancy, reflecting recent guidelines JO - Ir J Med Sci VL - 188 UR - https://doi.org/10.1007/s11845-018-1829-7 DO - 10.1007/s11845-018-1829-7 ID - Murray2019 ER - TY - JOUR AU - Ledingham, J. AU - Gullick, N. AU - Irving, K. AU - Gorodkin, R. AU - Aris, M. AU - Burke, J. PY - 2017 DA - 2017// TI - BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs JO - Rheumatology. VL - 56 UR - https://doi.org/10.1093/rheumatology/kew479 DO - 10.1093/rheumatology/kew479 ID - Ledingham2017 ER - TY - JOUR AU - Price, S. AU - James, C. AU - Deighton, C. PY - 2010 DA - 2010// TI - Methotrexate use and alcohol JO - Clin Experimental Rheumatology-Incl Supplements VL - 28 ID - Price2010 ER - TY - JOUR AU - Scirè, C. A. AU - Caporali, R. AU - Sarzi-Puttini, P. AU - Frediani, B. AU - Franco, M. AU - Tincani, A. PY - 2013 DA - 2013// TI - Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database JO - Clin Exp Rheumatol VL - 31 ID - Scirè2013 ER - TY - JOUR AU - Carmona, L. AU - Gómez-Reino, J. J. PY - 2006 DA - 2006// TI - Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER JO - Arthritis Res Therapy VL - 8 UR - https://doi.org/10.1186/ar1941 DO - 10.1186/ar1941 ID - Carmona2006 ER - TY - JOUR AU - Souto, A. AU - Maneiro, J. R. AU - Gómez-Reino, J. J. PY - 2015 DA - 2015// TI - Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases JO - Rheumatology. VL - 55 ID - Souto2015 ER - TY - JOUR AU - Saad, A. A. AU - Ashcroft, D. M. AU - Watson, K. D. AU - Hyrich, K. L. AU - Noyce, P. R. AU - Symmons, D. P. M. PY - 2009 DA - 2009// TI - Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register JO - Arthritis Research Therapy. VL - 11 UR - https://doi.org/10.1186/ar2670 DO - 10.1186/ar2670 ID - Saad2009 ER -